Evidence map›Paper›PMID 27340278›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.

Hyunseok Kang, Marietta Tan, Justin A Bishop, Siân Jones, Mark Sausen, Patrick K Ha, Nishant Agrawal

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Molecular Biology of MEC Salivary Gland Tumors.Annals of otolaryngology and rhinology · 2025
    Article
  7. Article
  8. Unique Cohorts of Salivary Gland Cancer Cells as anJournal of maxillofacial and oral surgery · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. HIV-1 reservoir evolution in infants infected with clade C from Mozambique.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hyunseok KangDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Marietta TanDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Justin A BishopDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Siân JonesPersonal Genome Diagnostics, Baltimore, Maryland.
Mark SausenPersonal Genome Diagnostics, Baltimore, Maryland.
Patrick K HaDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Nishant AgrawalDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. nishant.agrawal@uchicago.edu.
Johns Hopkins University · USHuman Genome Sciences (United States) · US

Funding

TUMOR SUPPRESOR GENE PROMOTER HYPERMETHYLATION FOR DETECTION OF HEAD AND NECKP50DE019032 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI SIDRANSKY, DAVID · 2007 to 2016
$27.1M
Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Genome Wide Discovery of Molecular Alterations in Salivary Gland TumorsR21DE023218 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI AGRAWAL, NISHANT · 2012 to 2013
$437k
NIDCR NIH HHS P50 DE019032NIDCR NIH HHS R21 DE023218NIGMS NIH HHS T32 GM008752
6 · The paper itself

Abstract

purposeMucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy. To explore the genetic origins of MEC, we performed systematic genomic analyses of these tumors. EXPERIMENTAL

designWhole-exome sequencing and gene copy-number analyses were performed for 18 primary cancers with matched normal tissue. FISH was used to determine the presence or absence of the MECT1-MAML2 translocation in 17 tumors.

resultsTP53 was the most commonly mutated gene in MEC (28%), and mutations were found only in intermediate- and high-grade tumors. Tumors with TP53 mutations had more mutations overall than tumors without TP53 mutations (P = 0.006). POU6F2 was the second most frequently mutated gene, found in three low-grade MECs with the same in-frame deletion. Somatic alterations in IRAK1, MAP3K9, ITGAL, ERBB4, OTOGL, KMT2C, and OBSCN were identified in at least two of the 18 tumors sequenced. FISH analysis confirmed the presence of the MECT1-MAML2 translocation in 15 of 17 tumors (88%).

conclusionsThrough these integrated genomic analyses, MECT1-MAML2 translocation and somatic TP53 and POU6F2 mutations appear to be the main drivers of MEC. Clin Cancer Res; 23(1); 283-8. ©2016 AACR.

Indexed as

ExomeExome SequencingAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, MucoepidermoidDNA Copy Number VariationsFemaleGenomicsHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedMutationNeoplasm GradingBiomarkers, TumorMECT1-MAML2 fusion protein, humanOncogene Proteins, Fusion

Identifiers

PMID27340278
PMCPMC5182193
OpenAlexW2464731156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.